Location History:
- Engelwood, NJ (US) (1997)
- Englewood, NJ (US) (1998 - 2023)
Company Filing History:
5 out of 15 
3 out of 21 
2 out of 2 
Years Active: 1997-2023
Title: Itzhak D Goldberg: Innovator in Pharmaceutical Chemistry
Introduction
Itzhak D Goldberg is a prominent inventor based in Englewood, NJ (US), known for his significant contributions to pharmaceutical chemistry. With a total of 13 patents to his name, Goldberg has made remarkable advancements in the field, particularly in the development of compounds that target critical biological pathways.
Latest Patents
Goldberg's latest patents include innovative compounds such as vinylheterocycles that act as Rho-associated coiled-coil kinase (ROCK) inhibitors. These compounds are designed to provide therapeutic benefits in treating various conditions by inhibiting ROCK1 and ROCK2. Another notable patent involves small-molecule modulators of hepatocyte growth factor/scatter factor activities. This invention focuses on organic molecules that can either mimic or inhibit HGF/SF activity, which is crucial for promoting tissue healing and addressing inflammatory diseases, including cancer.
Career Highlights
Throughout his career, Itzhak D Goldberg has worked with esteemed institutions such as North Shore University Hospital Research Corporation and North Shore-LIJ Research Institute. His work has significantly impacted the understanding and treatment of various medical conditions through innovative pharmaceutical solutions.
Collaborations
Goldberg has collaborated with notable professionals in his field, including Eliot M Rosen and Sivaram Pillarisetti. These partnerships have further enhanced his research and development efforts, leading to groundbreaking inventions.
Conclusion
Itzhak D Goldberg's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading inventor in the industry. His work continues to pave the way for advancements in medical treatments and therapies.